PD Hinduja Hospital and Medical Research Centre has joined hands with the US’ Division of AIDS (DAIDS) to set up a centre for research for infectious diseases in India.
The hospital today signed a Letter of Intent (LoI) with the DAIDS, a Division within the National Institute of Allergy and Infectious Diseases (NIAID), to establish the centre.
“Hinduja Hospital has signed an LoI with the DAIDS, a Division within the US’ National Institute of Allergy and Infectious Diseases (NIAID), to address the issue of increasing number of cases of TB and HIV,” the company said in a statement here.
NIAID is a part of the National Institutes of Health(NIH), a part of the US Department of Health and Human Services.
Under the LoI, a centre of excellence linked to the hospital, Hinduja Institute for Medical Research and Training (HIMAT), will be established.
“Our team’s research work and globally recognised achievements in the field of TB, from research-based TB rapid diagnosis to successful treatment of MDR/XDR/TDR TB patients, has proven the importance and connection between research and diagnosis. Now we are taking a step further to bring contributors to the subject of TB together under one roof along with the Division of AIDS,” hospital’s Managing Trustee Vinoo Hinduja said.
While the hospital’s research community has undertaken and processed close to 1,000 projects, tuberculosis has been an extremely active research area, she said.
“With over 35 international research projects, the Hinduja hospital research team has had at least 10 international collaborations in the field of TB and the LoI with NIAID, NIH will only fortify this commitment in research for infectious diseases,” Hinduja added.
